Abeona Therapeutics Inc. (LON:0H7R)

Abeona Therapeutics Statistics

Total Valuation

LON:0H7R has a market cap or net worth of GBP 198.51 million. The enterprise value is 64.16 million.

Market Cap	198.51M
Enterprise Value	64.16M

Important Dates

The next estimated earnings date is Friday, March 20, 2026.

Earnings Date	Mar 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	54.19M
Shares Outstanding	n/a
Shares Change (YoY)	+74.23%
Shares Change (QoQ)	-18.60%
Owned by Insiders (%)	12.23%
Owned by Institutions (%)	55.26%
Float	39.95M

Valuation Ratios

The trailing PE ratio is 3.24.

PE Ratio	3.24
Forward PE	n/a
PS Ratio	667.10
PB Ratio	1.56
P/TBV Ratio	1.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	1.05
EV / Sales	218.51
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.05

Financial Position

The company has a current ratio of 9.74, with a Debt / Equity ratio of 0.14.

Current Ratio	9.74
Quick Ratio	9.41
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	-0.29
Interest Coverage	-21.13

Financial Efficiency

Return on equity (ROE) is 75.90% and return on invested capital (ROIC) is -39.37%.

Return on Equity (ROE)	75.90%
Return on Assets (ROA)	-29.57%
Return on Invested Capital (ROIC)	-39.37%
Return on Capital Employed (ROCE)	-39.83%
Weighted Average Cost of Capital (WACC)	10.96%
Revenue Per Employee	2,188
Profits Per Employee	450,467
Employee Count	136
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, LON:0H7R has paid 234,341 in taxes.

Income Tax	234,341
Effective Tax Rate	0.38%

Stock Price Statistics

The stock price has decreased by -13.18% in the last 52 weeks. The beta is 1.13, so LON:0H7R's price volatility has been higher than the market average.

Beta (5Y)	1.13
52-Week Price Change	-13.18%
50-Day Moving Average	5.15
200-Day Moving Average	5.71
Relative Strength Index (RSI)	46.38
Average Volume (20 Days)	7,655

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	9.34

Income Statement

In the last 12 months, LON:0H7R had revenue of GBP 297,576 and earned 61.26 million in profits. Earnings per share was 0.96.

Revenue	297,576
Gross Profit	-21.78M
Operating Income	-61.90M
Pretax Income	61.50M
Net Income	61.26M
EBITDA	-60.25M
EBIT	-61.90M
Earnings Per Share (EPS)	0.96

Balance Sheet

The company has 154.08 million in cash and 17.93 million in debt, with a net cash position of 136.15 million.

Cash & Cash Equivalents	154.08M
Total Debt	17.93M
Net Cash	136.15M
Net Cash Per Share	n/a
Equity (Book Value)	127.39M
Book Value Per Share	2.43
Working Capital	144.29M

Cash Flow

In the last 12 months, operating cash flow was -55.74 million and capital expenditures -5.53 million, giving a free cash flow of -61.27 million.

Operating Cash Flow	-55.74M
Capital Expenditures	-5.53M
Free Cash Flow	-61.27M
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-20,802.25%
Pretax Margin	20,666.25%
Profit Margin	20,587.50%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0H7R does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-74.23%
Shareholder Yield	-74.23%
Earnings Yield	30.86%
FCF Yield	-30.87%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 5, 2022. It was a reverse split with a ratio of 0.04.

Last Split Date	Jul 5, 2022
Split Type	Reverse
Split Ratio	0.04

Scores

LON:0H7R has an Altman Z-Score of -1.74 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.74
Piotroski F-Score	3